Rosacea: Part I. Introduction, categorization, histology, pathogenesis, and risk factors

Journal of the American Academy of Dermatology

Volumn 72, Issue 5, 2015, Pages 749-758

  Two, Aimee M ^a   Wu, Wiggin ^a   Gallo, Richard L ^a   Hata, Tissa R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cathelicidin; mast cells; matrix metalloproteinases; microbiome; rosacea; serine proteases; transient receptor potential channels; ultraviolet radiation

Indexed keywords

ARTICLE; BACILLUS; BACILLUS OLERONIUS; DEMODEX FOLLICULORUM; DISEASE CLASSIFICATION; ERYTHEMATOTELANGIECTATIC ROSACEA; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNE DYSREGULATION; INNATE IMMUNITY; MOLECULAR PATHOLOGY; OCULAR ROSACEA; PAPULOPUSTULAR ROSACEA; PATHOGENESIS; PATHOPHYSIOLOGY; PHYMATOUS ROSACEA; PRIORITY JOURNAL; RISK FACTOR; ROSACEA; SKIN BIOPSY; SKIN FUNCTION; STAPHYLOCOCCUS EPIDERMIDIS; ULTRAVIOLET RADIATION; CLASSIFICATION; IMMUNE SYSTEM; IMMUNOLOGY; MICROBIOLOGY; NERVOUS SYSTEM; PATHOLOGY; SKIN;

HUMANS; IMMUNE SYSTEM; NERVOUS SYSTEM; RISK FACTORS; ROSACEA; SKIN; ULTRAVIOLET RAYS;

EID: 84928261731     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.08.028     Document Type: Review

References (78)

1. J. Wilkin, M. Dahl, and M. Detmar et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea J Am Acad Dermatol 46 2002 584 587
2. J. Tan, U. Blume-Peytavi, and J.P. Ortonne et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes Br J Dermatol 169 2013 555 562
3. R. Marks, and E.W. Jones Disseminated rosacea Br J Dermatol 81 1969 16 28
4. G.H. Crawford, M.T. Pelle, and W.D. James Rosacea: I. Etiology, pathogenesis, and subtype classification J Am Acad Dermatol 51 2004 327 341
5. K.P. Kyriakis, I. Palamaras, S. Terzoudi, S. Emmanuelides, C. Michailides, and G. Pagana Epidemiologic aspects of rosacea J Am Acad Dermatol 53 2005 918 919
6. A.A. Ramelet Rosacea: a reaction pattern associated with ocular lesions and migraine? Arch Dermatol 130 1994 1448
7. M.J. Quarterman, D.W. Johnson, D.C. Abele, J.L. Lesher Jr., D.S. Hull, and L.S. Davis Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline Arch Dermatol 133 1997 49 54
8. E.K. Akpek, A. Merchant, V. Pinar, and C.S. Foster Ocular rosacea: patient characteristics and follow-up Ophthalmology 104 1997 1863 1867
9. R. Odom, M. Dahl, and J. Dover et al. Standard management options for rosacea, part 1: overview and broad spectrum of care Cutis 84 2009 43 47
10. E. Lazaridou, C. Fotiadou, N.G. Ziakas, C. Giannopoulou, Z. Apalla, and D. Ioannides Clinical and laboratory study of ocular rosacea in northern Greece J Eur Acad Dermatol Venereol 25 2011 1428 1431
11. V.C. Ghanem, N. Mehra, S. Wong, and M.J. Mannis The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics Cornea 22 2003 230 233
12. M. Oltz, and J. Check Rosacea and its ocular manifestations Optometry 82 2011 92 103
13. R. Marks, and J.N. Harcourt-Webster Histopathology of rosacea Arch Dermatol 100 1969 683 691
14. F. Aloi, C. Tomasini, E. Soro, and M. Pippione The clinicopathologic spectrum of rhinophyma J Am Acad Dermatol 42 2000 468 472
15. K. Yamasaki, A. Di Nardo, and A. Bardan et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea Nat Med 13 2007 975 980
16. K. Yamasaki, J. Schauber, and A. Coda et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin FASEB J 20 2006 2068 2080
17. R. Koczulla, G. von Degenfeld, and C. Kupatt et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 J Clin Invest 111 2003 1665 1672
18. S. Morizane, K. Yamasaki, and B. Muhleisen et al. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands J Invest Dermatol 132 2012 135 143
19. J. Schauber, R.A. Dorschner, and A.B. Coda et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism J Clin Invest 117 2007 803 811
20. A. Di Nardo, A. Vitiello, and R.L. Gallo Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide J Immunol 170 2003 2274 2278
21. B. Koller, A.S. Muller-Wiefel, R. Rupec, H.C. Korting, and T. Ruzicka Chitin modulates innate immune responses of keratinocytes PLoS One 6 2011 e16594
22. N. Lacey, S. Delaney, K. Kavanagh, and F.C. Powell Mite-related bacterial antigens stimulate inflammatory cells in rosacea Br J Dermatol 157 2007 474 481
23. Y.H. Jang, J.H. Sim, H.Y. Kang, Y.C. Kim, and E.S. Lee Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea J Eur Acad Dermatol Venereol 25 2011 544 548
24. Y. Muto, Z. Wang, M. Vandenberghe, A. Two, R.L. Gallo, and A. Di Nardo Mast cells are key mediators of cathelicidin initiated skin inflammation in rosacea J Invest Dermatol 134 2014 2728 2736
25. V.D. Schwab, M. Sulk, and S. Seeliger et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea J Investig Dermatol Symp Proc 15 2011 53 62
26. K. Aroni, E. Tsagroni, N. Kavantzas, E. Patsouris, and E. Ioannidis A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process Arch Dermatol Res 300 2008 125 131
27. F. Forton, B. Seys, J.L. Marchal, and A.M. Song Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy Br J Dermatol 138 1998 461 466
28. M.V. Dahl, A.J. Ross, and P.M. Schlievert Temperature regulates bacterial protein production: possible role in rosacea J Am Acad Dermatol 50 2004 266 272
29. A. Rebora, F. Drago, and A. Picciotto Helicobacter pylori in patients with rosacea Am J Gastroenterol 89 1994 1603 1604
30. N. Lacey, K. Kavanagh, and S.C. Tseng Under the lash: Demodex mites in human diseases Biochem (London) 31 2009 2 6
31. S. Jarmuda, N. O'Reilly, R. Zaba, O. Jakubowicz, A. Szkaradkiewicz, and K. Kavanagh Potential role of Demodex mites and bacteria in the induction of rosacea J Med Microbiol 61 2012 1504 1510
32. Y.E. Zhao, L.P. Wu, Y. Peng, and H. Cheng Retrospective analysis of the association between Demodex infestation and rosacea Arch Dermatol 146 2010 896 902
33. C. Casas, C. Paul, and M. Lahfa et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation Exp Dermatol 21 2012 906 910
34. H. Moravvej, M. Dehghan-Mangabadi, M.R. Abbasian, and G. Meshkat-Razavi Association of rosacea with demodicosis Arch Iran Med 10 2007 199 203
35. T. Roihu, and A.L. Kariniemi Demodex mites in acne rosacea J Cutan Pathol 25 1998 550 552
36. R.R. Bonamigo, L. Bakos, M. Edelweiss, and A. Cartell Could matrix metalloproteinase-9 be a link between Demodex folliculorum and rosacea? J Eur Acad Dermatol Venereol 19 2005 646 647
37. M. Kocak, S. Yagli, G. Vahapoglu, and M. Eksioglu Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study Dermatology 205 2002 265 270
38. L. Ferrer, I. Favera, and K. Silbermayr Immunology and pathogenesis of canine demodecosis Vet Dermatol 25 2014 427-e65
39. M.C. Bastos, H. Ceotto, M.L. Coelho, and J.S. Nascimento Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications Curr Pharm Biotechnol 10 2009 38 61
40. A.L. Cogen, K. Yamasaki, and J. Muto et al. Staphylococcus epidermidis antimicrobial delta-toxin (phenol-soluble modulin-gamma) cooperates with host antimicrobial peptides to kill group A Streptococcus PloS One 5 2010 e8557
41. A.L. Cogen, K. Yamasaki, and K.M. Sanchez et al. Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin J Invest Dermatol 130 2010 192 200
42. R.L. Gallo, and T. Nakatsuji Microbial symbiosis with the innate immune defense system of the skin J Invest Dermatol 131 2011 1974 1980
43. M. Whitfeld, N. Gunasingam, L.J. Leow, K. Shirato, and V. Preda Staphylococcus epidermidis: a possible role in the pustules of rosacea J Am Acad Dermatol 64 2011 49 52
44. I. Wanke, H. Steffen, and C. Christ et al. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways J Invest Dermatol 131 2011 382 390
45. E. Lazaridou, C. Giannopoulou, C. Fotiadou, E. Vakirlis, A. Trigoni, and D. Ioannides The potential role of microorganisms in the development of rosacea J Dtsch Dermatol Ges 9 2011 21 25
46. Y. Tuzun, S. Keskin, and E. Kote The role of Helicobacter pylori infection in skin diseases: facts and controversies Clin Dermatol 28 2010 478 482
47. M.A. Mc Aleer, N. Lacey, and F.C. Powell The pathophysiology of rosacea G Ital Dermatol Venereol 144 2009 663 671
48. E. Lazaridou, Z. Apalla, S. Sotiraki, N.G. Ziakas, C. Fotiadou, and D. Ioannides Clinical and laboratory study of rosacea in northern Greece J Eur Acad Dermatol Venereol 24 2010 410 414
49. R.R. Bonamigo, C.S. Leite, M. Wagner, and L. Bakos Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association J Eur Acad Dermatol Venereol 14 2000 424 425
50. A. Szlachcic The link between Helicobacter pylori infection and rosacea J Eur Acad Dermatol Venereol 16 2002 328 333
51. G. Argenziano, G. Donnarumma, M.R. Iovene, P. Arnese, M.A. Baldassarre, and A. Baroni Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients Int J Dermatol 42 2003 601 604
52. N. O'Reilly, D. Bergin, E.P. Reeves, N.G. McElvaney, and K. Kavanagh Demodex-associated bacterial proteins induce neutrophil activation Br J Dermatol 166 2012 753 760
53. O. Bakar, Z. Demircay, M. Yuksel, G. Haklar, and Y. Sanisoglu The effect of azithromycin on reactive oxygen species in rosacea Clin Exp Dermatol 32 2007 197 200
54. J. Li, N. O'Reilly, and H. Sheha et al. Correlation between ocular Demodex infestation and serum immunoreactivity to bacillus proteins in patients with facial rosacea Ophthalmology 117 2010 870 877.e1
55. N. O'Reilly, N. Menezes, and K. Kavanagh Positive correlation between serum immunoreactivity to Demodex-associated bacillus proteins and erythematotelangiectatic rosacea Br J Dermatol 167 2012 1032 1036
56. M.A. McAleer, P. Fitzpatrick, and F.C. Powell Papulopustular rosacea: prevalence and relationship to photodamage J Am Acad Dermatol 63 2010 33 39
57. E. Naru, T. Suzuki, and M. Moriyama et al. Functional changes induced by chronic UVA irradiation to cultured human dermal fibroblasts Br J Dermatol 153 suppl 2 2005 6 12
58. Y. Kawaguchi, H. Tanaka, and T. Okada et al. The effects of ultraviolet A and reactive oxygen species on the mRNA expression of 72-kDa type IV collagenase and its tissue inhibitor in cultured human dermal fibroblasts Arch Dermatol Res 288 1996 39 44
59. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes J Biol Chem 271 1996 21793 21797
60. C. Ballaun, W. Weninger, A. Uthman, H. Weich, and E. Tschachler Human keratinocytes express the three major splice forms of vascular endothelial growth factor J Invest Dermatol 104 1995 7 10
61. D.R. Bielenberg, C.D. Bucana, R. Sanchez, C.K. Donawho, M.L. Kripke, and I.J. Fidler Molecular regulation of UVB-induced cutaneous angiogenesis J Invest Dermatol 111 1998 864 872
62. D. Jones Reactive oxygen species and rosacea Cutis 74 2004 17 20 32-4
63. K. Yamasaki, and R.L. Gallo The molecular pathology of rosacea J Dermatol Sci 55 2009 77 81
64. R. Graepel, E.S. Fernandes, A.A. Aubdool, D.A. Andersson, S. Bevan, and S.D. Brain 4-oxo-2-nonenal (4-ONE): evidence of transient receptor potential ankyrin 1-dependent and -independent nociceptive and vasoactive responses in vivo J Pharmacol Exp Ther 337 2011 117 124
65. L. Pecze, K. Szabo, and M. Szell et al. Human keratinocytes are vanilloid resistant PloS One 3 2008 e3419
66. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
67. S. Earley Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle Microcirculation 17 2010 237 249
68. M. Sulk, S. Seeliger, and J. Aubert et al. Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea J Invest Dermatol 132 2012 1253 1262
69. D.A. Andersson, C. Gentry, and L. Alenmyr et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid delta(9)-tetrahydrocannabiorcol Nat Commun 2 2011 551
70. G. Pozsgai, J.V. Bodkin, R. Graepel, S. Bevan, D.A. Andersson, and S.D. Brain Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo Cardiovasc Res 87 2010 760 768
71. Y. Dai, S. Wang, and M. Tominaga et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain J Clin Invest 117 2007 1979 1987
72. M. Steinhoff, J. Buddenkotte, and V. Shpacovitch et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response Endocr Rev 26 2005 1 43
73. A.A. Aubdool, and S.D. Brain Neurovascular aspects of skin neurogenic inflammation J Investig Dermatol Symp Proc 15 2011 33 39
74. T. Dirschka, H. Tronnier, and R. Folster-Holst Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis Br J Dermatol 150 2004 1136 1141
75. S. Ni Raghallaigh, and F.C. Powell Epidermal hydration levels in rosacea patients improve after minocycline therapy Br J Dermatol 171 2014 259 266
76. J.P. Hachem, E. Houben, and D. Crumrine et al. Serine protease signaling of epidermal permeability barrier homeostasis J Invest Dermatol 126 2006 2074 2086
77. J. Spoendlin, J.J. Voegel, S.S. Jick, and C.R. Meier Risk of rosacea in patients with diabetes using insulin or oral antidiabetic drugs J Invest Dermatol 133 2013 2790 2793
78. N. Duman, S. Ersoy Evans, and N. Atakan Rosacea and cardiovascular risk factors: a case control study J Eur Acad Dermatol Venereol 28 2014 1165 1169